Literature DB >> 20376526

Antibiotic treatment can be safely stopped in asymptomatic patients with prosthetic joint infections despite persistent elevated C-reactive protein values.

R J Piso1, R Elke.   

Abstract

OBJECTIVE: Prosthetic joint infection should be treated for a prolonged time (3 months for hip, 6 months for knee infection). Most authors require normalization of CRP before stopping antimicrobial therapy. However, in some patients the CRP values remain slightly elevated despite adequate treatment.
METHOD: We observed 14 patients with prosthetic joint infection (6 knee, 9 hip infections), in whom the CRP values never fell below the upper limit of normal. Eleven patients were surgically treated with débridement and retention of the prosthesis, in one patient one-staged reimplantation and in two patients two-staged reimplantations were performed. Antibiotic treatment was stopped according the guidelines, if the patient was clinically without signs of persistent infection and the CRP values reached a plateau, albeit above the cut-off (5 mg/L). All patients were followed for 2 years after primary diagnosis of infection.
RESULTS: Only one patient developed a periprosthetic infection five months after stopping antibiotic therapy. However, the isolated pathogen was different from that of the patient's first infection, so we postulate a reinfection rather than a relapse. All other patients remained free of infection for the observed period.
CONCLUSION: Antibiotic treatment can safely be stopped in patients with prosthetic joint infection, even if CRP is not normalized, given that there are no clinical signs of persistent infection and a plateau of CRP level is obtained.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20376526     DOI: 10.1007/s15010-010-0019-y

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  11 in total

Review 1.  Prosthetic-joint infections.

Authors:  Werner Zimmerli; Andrej Trampuz; Peter E Ochsner
Journal:  N Engl J Med       Date:  2004-10-14       Impact factor: 91.245

2.  Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.

Authors:  C A Aboltins; M A Page; K L Buising; A W J Jenney; J R Daffy; P F M Choong; P A Stanley
Journal:  Clin Microbiol Infect       Date:  2007-02-28       Impact factor: 8.067

Review 3.  Management of infection associated with prosthetic joints.

Authors:  W Zimmerli; P E Ochsner
Journal:  Infection       Date:  2003-03       Impact factor: 3.553

4.  [Total prosthetic knee and hip joint infection. Descriptive epidemiology, therapeutics and evolution in a secondary hospital during ten years].

Authors:  A Jover Sáenz; F Barcenilla Gaite; J Torres Puig Gros; J Mas Atance; S Garrido Calvo; J M Porcel Pérez
Journal:  An Med Interna       Date:  2007-01

Review 5.  Immunomodulatory effects of macrolide antibiotics in respiratory disease: therapeutic implications for asthma and cystic fibrosis.

Authors:  Sanjiv Sharma; Adam Jaffe; Garth Dixon
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  Outcome of prosthetic joint infections treated with debridement and retention of components.

Authors:  C E Marculescu; E F Berbari; A D Hanssen; J M Steckelberg; S W Harmsen; J N Mandrekar; D R Osmon
Journal:  Clin Infect Dis       Date:  2006-01-05       Impact factor: 9.079

Review 7.  Mechanisms and management of antibiotic-associated diarrhea.

Authors:  C Högenauer; H F Hammer; G J Krejs; E C Reisinger
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

8.  [Effects of antibiotics on production of cytokines by human monocytes].

Authors:  S Bailly; M Fay; M A Gougerot-Pocidalo
Journal:  Pathol Biol (Paris)       Date:  1993-10

9.  A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma.

Authors:  Maud M Gueders; Pascal Bertholet; Fabienne Perin; Natacha Rocks; Raphaël Maree; Vincent Botta; Renaud Louis; Jean-Michel Foidart; Agnès Noel; Brigitte Evrard; Didier D Cataldo
Journal:  Biochem Pharmacol       Date:  2007-09-18       Impact factor: 5.858

Review 10.  Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies.

Authors:  Aydin Nazmi; Cesar G Victora
Journal:  BMC Public Health       Date:  2007-08-17       Impact factor: 3.295

View more
  2 in total

1.  Prosthetic joint infections: what to do if the C-reactive protein level remains elevated.

Authors:  C Ruef
Journal:  Infection       Date:  2010-08       Impact factor: 3.553

Review 2.  Treatment of Prosthetic Joint Infection with Debridement, Antibiotics and Irrigation with Implant Retention - a Narrative Review.

Authors:  Ricardo Sousa; Miguel Araújo Abreu
Journal:  J Bone Jt Infect       Date:  2018-06-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.